Related Party Transactions

9 Months Ended

Sep. 30, 2023

Related Party Transactions [Abstract]

Related Party Transactions

16.Related Party Transactions

The former Chief Executive Officer and current Executive Vice Chair of the Board of Directors of the Company (the Board), joined the Board of Directors of Altasciences Company Inc. (Altasciences) in April 2021. In May 2021, Altasciences acquired Calvert Laboratories, Inc. (Calvert Labs), an entity with which the Company conducts business. The Company recorded $413,000 and $1.3 million of research and development expense in the accompanying condensed consolidated statements of operations and comprehensive loss related to preclinical and analytical services provided by Altasciences for the three and nine months ended September 30, 2023, respectively. The Company recorded $237,000 and $1.5 million of research and development expense in the accompanying condensed consolidated statements of operations and comprehensive loss related to preclinical and analytical services provided by Altasciences for the three and nine months ended September 30, 2022, respectively. Additionally, the Company recorded accounts payable of $469,000 and $201,000, and prepaid expenses of $610,000 and $752,000 in the accompanying condensed consolidated balance sheets related to services provided by Altasciences, as of September 30, 2023 and December 31, 2022, respectively.